General Cannabis Stock Forecast, Price & News

-0.04 (-8.89 %)
(As of 09/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume86,795 shs
Average Volume85,837 shs
Market Capitalization$25.56 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CANN News and Ratings via Email

Sign-up to receive the latest news and ratings for General Cannabis and its competitors with MarketBeat's FREE daily newsletter.

General Cannabis logo

About General Cannabis

General Cannabis Corp. is a holding company, which is engaged in the provision of lease growing space and related facilities to licensed marijuana business operators. It operates through the following segments: Security, Operations, Consumer Goods, and Investments. The Security segment provides advanced security, including on-site professionals, video surveillance and cash transport, to licensed cannabis cultivators and retail shops. The Operations segment offers consulting services to the cannabis industry that include obtaining licenses, compliance, cultivation, retail operations, logistical support, facility design and building services, and expansion of existing operations. The Consumer Goods segment includes pursuing relationships with non-cannabis national and regional apparel retailers and distributors, as well as expanding product line nationwide within the cannabis industry. The Investments segment includes expanding portfolio of loans, potentially launching a loan origination and servicing business, and investing in high-growth potential companies within the cannabis industry. The company was founded on November 12, 1987 and is headquartered in Denver, CO.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.16 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

General Cannabis (OTCMKTS:CANN) Frequently Asked Questions

What stocks does MarketBeat like better than General Cannabis?

Wall Street analysts have given General Cannabis a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but General Cannabis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting General Cannabis?

General Cannabis saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 133,100 shares, a decrease of 37.1% from the August 15th total of 211,500 shares. Based on an average trading volume of 247,700 shares, the days-to-cover ratio is presently 0.5 days.
View General Cannabis' Short Interest

When is General Cannabis' next earnings date?

General Cannabis is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for General Cannabis

How were General Cannabis' earnings last quarter?

General Cannabis Corp (OTCMKTS:CANN) posted its quarterly earnings data on Wednesday, August, 11th. The company reported ($0.02) earnings per share for the quarter. The firm had revenue of $0.70 million for the quarter. General Cannabis had a negative net margin of 102.94% and a negative trailing twelve-month return on equity of 825.51%.
View General Cannabis' earnings history

How has General Cannabis' stock been impacted by Coronavirus (COVID-19)?

General Cannabis' stock was trading at $0.4550 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CANN shares have decreased by 9.9% and is now trading at $0.41.
View which stocks have been most impacted by COVID-19

Who are General Cannabis' key executives?

General Cannabis' management team includes the following people:
  • Adam Lawrence Hershey, Chief Executive Officer & Director
  • Richard Cardinal, Vice President-Operations
  • Diane Jones, Chief Financial & Accounting Officer
  • Hunter Garth, Vice President-Corporate Development
  • Cindy Gonzales, Vice President-Marketing

Who are some of General Cannabis' key competitors?

What other stocks do shareholders of General Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other General Cannabis investors own include (CGC), Unrivaled Brands (TRTC), Aurora Cannabis (ACBFF), Cronos Group (CRON), GW Pharmaceuticals (GWPH), 22nd Century Group (XXII), Zynerba Pharmaceuticals (ZYNE), Cannabis Sativa (CBDS), Aurora Cannabis (ACB) and Alibaba Group (BABA).

What is General Cannabis' stock symbol?

General Cannabis trades on the OTCMKTS under the ticker symbol "CANN."

How do I buy shares of General Cannabis?

Shares of CANN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is General Cannabis' stock price today?

One share of CANN stock can currently be purchased for approximately $0.41.

How much money does General Cannabis make?

General Cannabis has a market capitalization of $25.56 million and generates $7.12 million in revenue each year.

How many employees does General Cannabis have?

General Cannabis employs 2,779 workers across the globe.

What is General Cannabis' official website?

The official website for General Cannabis is www.generalcann.com.

Where are General Cannabis' headquarters?

General Cannabis is headquartered at 6565 EAST EVANS AVENUE, DENVER CO, 80224.

How can I contact General Cannabis?

General Cannabis' mailing address is 6565 EAST EVANS AVENUE, DENVER CO, 80224. The company can be reached via phone at (303) 759-1300.

This page was last updated on 9/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.